5 ML doxorubicin hydrochloride 2 MG/ML Injection — RxCUI 1790097
RxNorm drug concept · Semantic clinical drug
RxCUI 1790097
Semantic clinical drug · SCD
● Current RxNorm concept 24 FDA products
29 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1790097
Official name5 ML doxorubicin hydrochloride 2 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdoxorubicin hydrochloride 10 MG per 5 ML Injection; DOXOrubicin HCl 10 MG in 5 mL Injection
FDA products mapped24
Package NDCs mapped29
Reported Medicaid activity (SDUD)10,065 prescriptions · 40 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Doxorubicin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It is a chemotherapy medicine for many cancers. Standard forms treat breast cancer, leukemias, lymphomas, and several spread cancers. Liposomal forms like Doxil treat ovarian cance...
- A healthcare professional gives it into a vein in treatment cycles, usually every few weeks. You do not take it by mouth. Your team sets the exact schedule.
- Tiredness, nausea, vomiting, mouth sores, diarrhea or constipation, rash, and low blood counts are common. Liposomal forms can cause hand-foot syndrome. Let your team know about an...
- Call right away for fever or chills, unusual bleeding, shortness of breath, leg swelling, a racing heartbeat, or pain, redness, or swelling where the IV is. Heart problems can also...
🕸️ Concept Web — How 5 ML doxorubicin hydrochloride 2 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
5 ML doxorubicin hydrochloride 2 MG/ML Injection
RxCUI 1790097 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Doxorubicin
3639IN -
Doxorubicin hydrochloride
142433PIN
-
Doxorubicin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Doxorubicin Injection
1790094SCDF -
Doxorubicin hydrochloride Injection
2645409SCDFP -
Doxorubicin Injectable Product
1160774SCDG -
Doxorubicin hydrochloride Injectable Product
2662060SCDGP -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Doxorubicin Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Doxorubicin hydrochloride 2 MG/ML
1191137SCDC
-
Doxorubicin hydrochloride 2 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Doxorubicin hydrochloride 2 MG/ML
SCDC · 1191137 -
Doxorubicin Injection
SCDF · 1790094 -
Doxorubicin hydrochloride Injection
SCDFP · 2645409 -
Doxorubicin Injectable Product
SCDG · 1160774 -
Doxorubicin hydrochloride Injectable Product
SCDGP · 2662060
📦 FDA Products & Package NDCs
24 products · 29 package NDCs
29 package NDCs map to RxCUI 1790097 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00069-0255-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-0255-10) / 10 mL in 1... | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | 2024-10-14 |
| 00069-0277-02 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-0277-02) / 10 mL in 1... | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | 2024-08-19 |
| 00069-0343-02 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-0343-02) / 25 mL in 1... | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | 2024-11-11 |
| 00069-0358-20 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-0358-20) / 5 mL in 1... | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | 2024-08-19 |
| 00069-1442-04 | 1 VIAL, MULTI-DOSE in 1 CARTON (0069-1442-04) / 100 mL in 1... | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | 2024-10-14 |
| 00069-1542-20 | 1 VIAL, MULTI-DOSE in 1 CARTON (0069-1542-20) / 100 mL in 1... | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | 2024-07-22 |
| 00069-3358-25 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-3358-25) / 25 mL in 1... | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | 2024-11-11 |
| 00069-4031-12 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-4031-12) / 10 mL in 1... | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | 2025-03-31 |
| 00069-4205-05 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-4205-05) / 5 mL in 1... | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | 2024-11-11 |
| 00069-5629-05 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-5629-05) / 5 mL in 1... | Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | 2025-03-31 |
| 00143-9084-01 | 1 VIAL in 1 BOX (0143-9084-01) / 5 mL in 1 VIAL | Doxorubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 1996-05-01 |
| 00143-9085-01 | 1 VIAL in 1 BOX (0143-9085-01) / 10 mL in 1 VIAL | Doxorubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 1996-05-01 |
| 00143-9086-01 | 1 VIAL in 1 BOX (0143-9086-01) / 25 mL in 1 VIAL | Doxorubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 1996-05-01 |
| 00143-9087-01 | 1 VIAL, MULTI-DOSE in 1 BOX (0143-9087-01) / 100 mL in 1 VI... | Doxorubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 1996-05-01 |
| 00143-9088-01 | 1 VIAL in 1 BOX (0143-9088-01) / 5 mL in 1 VIAL | Doxorubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 2019-10-01 |
| 00143-9089-01 | 1 VIAL in 1 BOX (0143-9089-01) / 10 mL in 1 VIAL | Doxorubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 2019-10-01 |
| 00143-9090-01 | 1 VIAL in 1 BOX (0143-9090-01) / 25 mL in 1 VIAL | Doxorubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 2019-10-01 |
| 00143-9091-01 | 1 VIAL, MULTI-DOSE in 1 BOX (0143-9091-01) / 100 mL in 1 VI... | Doxorubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 2019-10-01 |
| 45963-0733-55 | 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-733-55) / 5 mL in 1... | Doxorubicin hydrochloride | Actavis Pharma, Inc. | 2014-11-01 |
| 45963-0733-57 | 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-733-57) / 10 mL in 1... | Doxorubicin hydrochloride | Actavis Pharma, Inc. | 2014-11-01 |
| 45963-0733-60 | 1 VIAL, MULTI-DOSE in 1 CARTON (45963-733-60) / 100 mL in 1... | Doxorubicin hydrochloride | Actavis Pharma, Inc. | 2014-11-01 |
| 45963-0733-68 | 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-733-68) / 25 mL in 1... | Doxorubicin hydrochloride | Actavis Pharma, Inc. | 2014-11-01 |
| 63323-0101-61 | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-101-61) / 100 mL in 1... | Doxorubicin Hydrochloride | Fresenius Kabi USA, LLC | 2000-06-14 |
| 63323-0883-05 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-883-05) / 5 mL in 1... | Doxorubicin Hydrochloride | Fresenius Kabi USA, LLC | 2000-04-14 |
| 63323-0883-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-883-10) / 10 mL in 1... | Doxorubicin Hydrochloride | Fresenius Kabi USA, LLC | 2000-04-14 |
| 63323-0883-30 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-883-30) / 25 mL in 1... | Doxorubicin Hydrochloride | Fresenius Kabi USA, LLC | 2000-04-14 |
| 68083-0248-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-248-01) / 5 mL in 1... | Doxorubicin Hydrochloride | Gland Pharma Limited | 2017-08-22 |
| 68083-0249-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-249-01) / 25 mL in 1... | Doxorubicin Hydrochloride | Gland Pharma Limited | 2017-08-22 |
| 68083-0250-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (68083-250-01) / 100 mL in 1... | Doxorubicin Hydrochloride | Gland Pharma Limited | 2017-08-22 |
Observed labelers:
Pfizer Laboratories Div Pfizer Inc (10) ·
Hikma Pharmaceuticals USA Inc. (8) ·
Actavis Pharma, Inc. (4) ·
Fresenius Kabi USA, LLC (4) ·
Gland Pharma Limited (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9000 | Doxorubicin hcl injection | 25 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.